STACIE CHENEY: Open Payments
NPI 1932988029 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 15 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $443 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Incyte Corporation | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| GENZYME CORPORATION | 1 | $18 |
| Caris MPI, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: SCEMBLIX, KEYTRUDA, JAKAFI, DATROWAY, LIBTAYO, Fabhalta, LYNPARZA, NERLYNX.
Industry payments across KY — which companies pay providers there.
